HomeCompareUBEOY vs PFE

UBEOY vs PFE: Dividend Comparison 2026

UBEOY yields 28.78% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UBEOY wins by $9720192.20M in total portfolio value
10 years
UBEOY
UBEOY
● Live price
28.78%
Share price
$7.82
Annual div
$2.25
5Y div CAGR
81.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9720192.25M
Annual income
$9,554,612,871,580.25
Full UBEOY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — UBEOY vs PFE

📍 UBEOY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUBEOYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UBEOY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UBEOY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UBEOY
Annual income on $10K today (after 15% tax)
$2,446.38/yr
After 10yr DRIP, annual income (after tax)
$8,121,420,940,843.21/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, UBEOY beats the other by $8,121,420,918,523.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UBEOY + PFE for your $10,000?

UBEOY: 50%PFE: 50%
100% PFE50/50100% UBEOY
Portfolio after 10yr
$4860096.15M
Annual income
$4,777,306,448,919.48/yr
Blended yield
98.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

UBEOY
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UBEOY buys
0
PFE buys
0
No recent congressional trades found for UBEOY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUBEOYPFE
Forward yield28.78%6.13%
Annual dividend / share$2.25$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR81.8%13.2%
Portfolio after 10y$9720192.25M$49.6K
Annual income after 10y$9,554,612,871,580.25$26,258.71
Total dividends collected$9709056.40M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: UBEOY vs PFE ($10,000, DRIP)

YearUBEOY PortfolioUBEOY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$15,932$5,232.39$9,153$693.39+$6.8KUBEOY
2$31,212$14,164.15$8,593$849.25+$22.6KUBEOY
3$80,542$47,145.34$8,336$1,066.78+$72.2KUBEOY
4$292,886$206,705.63$8,437$1,384.80+$284.4KUBEOY
5$1,590,526$1,277,138.70$9,013$1,875.40+$1.58MUBEOY
6$13,485,818$11,783,954.68$10,306$2,680.72+$13.48MUBEOY
7$184,190,703$169,760,878.30$12,820$4,101.38+$184.18MUBEOY
8$4,136,557,107$3,939,473,054.95$17,673$6,826.70+$4136.54MUBEOY
9$154,747,080,645$150,320,964,540.36$27,543$12,591.86+$154747.05MUBEOY
10$9,720,192,247,871$9,554,612,871,580.25$49,560$26,258.71+$9720192.20MUBEOY

UBEOY vs PFE: Complete Analysis 2026

UBEOYStock

Ube Industries, Ltd., together with its subsidiaries, engages in the chemicals, construction materials, and machinery businesses in Japan, Asia, Europe, and internationally. The company operates through four segments: Chemicals, Construction Materials, Machinery, and Others. It offers synthetic rubber, engineering plastics, caprolactam, industrial chemicals, liquefied gas, polyethylene, ammonium sulfate, polyimide, battery materials, separation membranes, fine chemicals, ceramics, high purity chemicals, semiconductor gas products, products for polyurethane resins, aerospace materials, inorganic fiber, and high temperature paints. The company also provides contract manufacturing services for APIs and intermediates; aromatic SF5 compounds; FLUOLEAD, a novel nucleophilic fluorinating agent; and drug discovery and pipeline services. In addition, it offers cement products, ready mixed concrete, soil stabilizing cement, building materials, limestone, calcia and magnesia, specialty inorganic materials, and resource recycling, as well as imports and sells coal. Further, the company is involved in the supply of electric power. Additionally, it provides die-casting and injection molding machines, and extrusion presses; and UBE vertical mills, kilins, furnaces, dryers, water screening equipment, storage and transportation systems, bridges and steel structures, and steel billets and casting. The company also manufactures and sells nylon, plastic films, polypropylene molded products, fibers, fiber-reinforced plastics, electronic and information materials, magnesia clinker, quicklime, slaked lime, and cast iron; and offers coastal shipping, port transportation, containers, collection and transport of industrial waste, trading, and engineering services. In addition, it engages in the purchase, sale, and leasing of real estate properties. Ube Industries, Ltd. was founded in 1897 and is headquartered in Tokyo, Japan.

Full UBEOY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this UBEOY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UBEOY vs SCHDUBEOY vs JEPIUBEOY vs OUBEOY vs KOUBEOY vs MAINUBEOY vs JNJUBEOY vs MRKUBEOY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.